Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
Mallinckrodt
Johnson and Johnson
Harvard Business School
Baxter
AstraZeneca

Last Updated: January 24, 2020

DrugPatentWatch Database Preview

DEXTROSE 50% IN PLASTIC CONTAINER Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Which patents cover Dextrose 50% In Plastic Container, and when can generic versions of Dextrose 50% In Plastic Container launch?

Dextrose 50% In Plastic Container is a drug marketed by Baxter Hlthcare, Hospira, and Icu Medical Inc. and is included in five NDAs.

The generic ingredient in DEXTROSE 50% IN PLASTIC CONTAINER is dextrose. There are nine drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the dextrose profile page.

Summary for DEXTROSE 50% IN PLASTIC CONTAINER
Drug patent expirations by year for DEXTROSE 50% IN PLASTIC CONTAINER

US Patents and Regulatory Information for DEXTROSE 50% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare DEXTROSE 50% IN PLASTIC CONTAINER dextrose INJECTABLE;INJECTION 017521-001 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
Icu Medical Inc DEXTROSE 50% IN PLASTIC CONTAINER dextrose INJECTABLE;INJECTION 018563-001 Mar 23, 1982 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
Baxter Hlthcare DEXTROSE 50% IN PLASTIC CONTAINER dextrose INJECTABLE;INJECTION 020047-001 Jul 2, 1991 AP RX Yes Yes   Start Trial   Start Trial   Start Trial
Hospira DEXTROSE 50% IN PLASTIC CONTAINER dextrose INJECTABLE;INJECTION 019445-001 Jun 3, 1986 RX Yes No   Start Trial   Start Trial   Start Trial
Icu Medical Inc DEXTROSE 50% IN PLASTIC CONTAINER dextrose INJECTABLE;INJECTION 019894-001 Dec 26, 1989 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
Merck
Johnson and Johnson
Medtronic
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.